Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02671435
Recruitment Status : Active, not recruiting
First Posted : February 2, 2016
Last Update Posted : October 7, 2021
Sponsor:
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 29, 2021
Estimated Study Completion Date : October 29, 2021